Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression.
Personality traits of patients with multiple sclerosis and their relationship with clinical characteristics.
Developing a community multiple sclerosis nursing service.
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.
Change of fate commitment in adult neural progenitor cells subjected to chronic inflammation.
Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review.
Enhanced myelination in autoimmunity and in normal development induced by glatiramer acetate.
MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis.
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
Accelerometer output and its association with energy expenditure in persons with multiple sclerosis.
Mitochondrial changes within axons in multiple sclerosis: an update.
Reported outcomes after the endovascular treatment of chronic cerebrospinal venous insufficiency.
A nurse-led mental health service for people with multiple sclerosis.
Neurocardiogenic Pulmonary Oedema: Initial Presentation of Multiple Sclerosis.
Atypical forms of optic neuritis.
Immunotherapy of Multiple Sclerosis : The State of the Art.
Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.
Top 10 Research Questions Related to Physical Activity and Multiple Sclerosis.
Psychological effects of calisthenic exercises on neuroinflammatory and rheumatic diseases.
Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?
Structural mechanism for statin inhibition of HMG-CoA reductase.
Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.
The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. By Douglas McAlpine. From the Institute of Clinical Research, The Middlesex Hospital Medical Sc
Journal Club: Intrathecal effects of daclizumab treatment of multiple sclerosis.
Lipid microarrays identify key mediators of autoimmune brain inflammation.

Pages